Essential Manual on Perfect 24-hour Blood Pressure Management from Morning to Nocturnal Hypertension:Up-to-date for Anticipation Medicine [単行本]

Essential Manual on Perfect 24-hour Blood Pressure Management from Morning to Nocturnal Hypertension:Up-to-date for Anticipation Medicine の 商品概要

• 目次

  Contents
  Author biography, x
  Preface, xii
  Acknowledgments, xvii
  
  CHAPTER 1 Out-of-clinic BP, 1
  SPRINT and automated office BP, 1
  Different clinical BP measurements, 1
  Diagnosis of hypertension and subtypes, 4
  
  CHAPTER 2 Morning and nocturnal hypertension as therapeutic
  targets, 7
  Definition of morning hypertension, 7
  Definition of nocturnal hypertension, 7
  Shift of the prevalence of morning hypertension by
  2017 AHA/ACC guidelines, 10
  When to use home and ambulatory BP monitoring, 11
  Staged management of morning and nocturnal hypertension, 14
  
  CHAPTER 3 Home BP monitoring and morning hypertension, 17
  How to measure home BP, 17
  Evidence for morning hypertension control, 21
  Subtypes of morning hypertension, 27
  
  CHAPTER 4 Ambulatory BP monitoring, 29
  ABPM parameters, 29
  Normal and typical patterns of ambulatory hypertension subtypes, 32
  Development of ICT-based multisensor-ABPM (IMS-ABPM), 32
  New ABPM indices, 33
  Anticipation of ambulatory BP, 44
  Multi-sensors and the real-time hybrid Wi-SUN/Wi-Fi
  transmission system, 46
  HI-JAMP registry, 49
  
  CHAPTER 5 Morning surge in BP, 51
  Definition of MBPS, 51
  Cardiovascular events with MBPS, 52
  Organ damage with MBPS, 54
  Hypertensive heart disease, 55
  Vascular disease and inflammation, 56
  Silent cerebrovascular disease, 58
  Chronic kidney disease, 59
  Determinants of MBPS, 61
  “Thermosensitive hypertension” and MBPS, 61
  Mechanism of morning risk, 63
  Haemostatic abnormality and MBPS, 68
  Vascular mechanism of exaggerated MBPS, 71
  
  CHAPTER 6 Nocturnal hypertension, 75
  Circadian rhythm of BP, 75
  Non-dipper/risers of nighttime BP, 75
  Cardiovascular risk, 76
  Organ damage and frailty, 80
  Definition and risk of nocturnal hypertension, 83
  Mechanism of nocturnal hypertension, 87
  Associated conditions of nocturnal hypertension, 89
  Diabetes, 89
  Chronic kidney disease, 90
  Sleep apnoea syndrome, 90
  Extreme dipper, 93
  
  CHAPTER 7 Development of nighttime home BP monitoring, 95
  Cutting-edge of home BP monitoring, 95
  Recommendation for nighttime home BP measurement, 95
  Basic nighttime home BP monitoring (Medinote), 97
  Trigger nighttime BP monitoring (TNP), 102
  IT-based trigger nighttime BP monitoring system, 107
  CPAP adherence and nighttime BP surge, 110
  Antihypertensive medication on nighttime BP surge, 115
  
  CHAPTER 8 Development of wearable beat-by-beat (surge) BP
  monitoring, 119
  
  CHAPTER 9 BP surge, 125
  BP variability with different time phase, 125
  The resonance hypothesis of BP surge, 125
  Evidence and mechanism of BP variability, 127
  Visit-to-visit variability in clinic BP, 128
  Ambulatory BP variability, 132
  Home BP variability, 132
  Maximum home SBP, 134
  Standard deviation of morning home BP, 136
  Morning-evening difference (ME-dif), 137
  Morning orthostatic hypertension, 138
  
  CHAPTER 10 What is systemic haemodynamic atherothrombotic
  syndrome?, 145
  A typical case of SHATS, 145
  Clinical relevance of SHATS, 148
  Pathological target of SHATS, 150
  Mechanism of vicious cycle of SHATS, 152
  
  CHAPTER 11 Biomarker of SHATS, 157
  Vascular biomarkers, 157
  1) CAVI/PWV, 157
  2) Central pressure, 162
  3) Flow-mediated dilatation (FMD), 163
  Cardiac biomarkers, 163
  1) NT-proBNP, 163
  2) High-sensitivity troponin T (hs-TNT) and growth differentiation factor
  15 (GDF-15), 167
  3) Electrocardiography (ECG), 167
  Microalbuminuria, 168
  Brain, 168
  Baroreflex sensitivity, 173
  
  CHAPTER 12 Antihypertensive strategy, 175
  Chronotherapy, 175
  Salt restriction, 177
  Drug treatment, 177
  
  CHAPTER 13 24-hour BP-lowering characteristics of drugs, 181
  Diuretics, 181
  Calcium channel blockers, 181
  Amlodipine, 181
  Nifedipine, 185
  Cilnidipine, 187
  Azelnidipine, 188
  Angiotensin-converting enzyme inhibitors, 188
  Angiotensin-receptor blockers (ARBs), 190
  Valsaratan, 190
  Telmisartan, 190
  Candesartan, 190
  Olmesartan, 192
  Azilsartan, 197
  Alpha-adrenergic blockers and beta-adrenergic blockers, 199
  Sacubitril/valsartan, 201
  SGLT2 inhibitor, 205
  
  CHAPTER 14 Combination therapy: Home and ambulatory
  BP-profile-based combination strategy, 211
  First-line therapy, 211
  Second-line therapy, 211
  Arterial stiffness type, 211
  Volume retention type, 212
  Third-line therapy, 214
  Evidence of RAS inhibitor-based combination, 214
  
  CHAPTER 15 Resistant hypertension and renal denervation, 227
  The strategies for the management of resistant hypertension, 227
  Fourth-line therapy, 227
  Era of renal denervation, 230
  Hypothesis of perfect 24-hour BP control by renal denervation, 231
  Evidence for renal denervation, 231
  Morning BP, 234
  Nighttime BP, 234
  Sleep apnoea, 235
  Isolated systolic hypertension, 235
  Potential beyond-BP effect, 235
  The Symplicity Spyral™ and evidence, 236
  Current potential candidates, 239
  Responders and future indication of renal denervation, 242
  
  CHAPTER 16 HOPE Asia Network, 245
  HOPE AsiaNetwork formation, 245
  Characteristics of cardiovascular disease in Asia, 249
  Obesity and salt intake in Asia, 249
  24-hour ambulatory BP profile in Asia, 255
  Facilitation of a home BP-guided approach in Asia, 256
  Asia BP@Home study, 258
  
  CHAPTER 17 Disaster hypertension and ICT-based
  home BP monitoring, 259
  Disaster hypertension, 259
  Disaster cardiovascular prevention (DCAP) network, 259
  ICT-based BP control: successful model of telemedicine, 266
  
  CHAPTER 18 Anticipation telemedicine, 269
  Anticipation medicine, 269
  Concept of event management, 269
  Innovation technology, 271
  Telemedicine and telecare, 272
  
  References, 275
  Index, 303

• 内容紹介

  【当書籍は英文記載となります】
  It is well known that cardiovascular events occur more frequently in the morning because blood pressure (BP) has been shown to increase during the period from night to early morning. In recent years, clinical research using ambulatory BP monitoring (ABPM) or home BP monitoring (HBPM) has clarified that morning BP, morning BP surge, and uncontrolled nocturnal hypertension are more closely associated with cardiovascular risk than clinic BP.
  
  This practical manual from a leading expert in the field, Dr. Kazuomi Kario, reviews recent evidence on “morning” and “nocturnal” hypertension, and provides guidance towards achieving the goal of “perfect 24-hour BP control”. This includes up-to-date information on his research and development of IT-based BP monitoring systems, facilitating “anticipation medicine” for zero cardiovascular events.

• 著者について

  Kazuomi Kario (カズオミ カリオ)
  Kazuomi Kario MD PhD FACC FACP FAHA FESC
  Professor
  Division of Cardiovascular Medicine, Department of Medicine,
  Center of Excellence, Cardiovascular Research and Development
  (JCARD),
  Jichi Medical University School of Medicine
  Hypertension Cardiovascular Outcome Prevention and Evidence
  (HOPE) Asia Network/World Hypertension League

Essential Manual on Perfect 24-hour Blood Pressure Management from Morning to Nocturnal Hypertension:Up-to-date for Anticipation Medicine の商品スペック